ABCs of secondary prevention of CHD: Easier said than done

Lancet

Volumn 357, Issue 9261, 2001, Pages 972-973

  Cohen, Jerome D ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; HYPOCHOLESTEROLEMIC AGENT; RAMIPRIL; STATIN;

ADULT; AGED; BEHAVIOR; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; DIET; EDUCATION; EXERCISE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NOTE; OBESITY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; SECONDARY PREVENTION; SMOKING; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035978065     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04252-5     Document Type: Note

References (18)

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
2. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
3. Preventing heart attack and death in patients with coronary heart disease
4. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention
5. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
6. When to start cholesterol-lowering therapy in patients with coronary heart disease: A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction
7. EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
8. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme
9. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period
10. The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
11. The Sixth Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
12. Prevention of ischaemic heart disease. General practitioners view: Part II: Secondary prevention
13. The results of the Coronary Health Assessment Study (CHAS)
14. The therapeutic gap: Compliance with medication and guidelines
15. After 4S, CARE and LIPID: Is evidence-based medicine being practiced?
16. Registration and management of smoking behavior in patients with coronary heart disease. The EUROASPIRE survey
17. International comparison of awareness and attitudes toward coronary risk factor reduction: The HELP study. Heart European Leaders Panel
18. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention